Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Persistently Increased Alloisoleucine in a Patient with Seizures.

Wiencek JR, Dietzen DJ, Murray T, Dawling S, Colby JM, Nichols JH.

Clin Chem. 2018 Oct;64(10):1433-1437. doi: 10.1373/clinchem.2017.278804. No abstract available.

2.

In Vitro Studies Indicate Intravenous Lipid Emulsion Acts as Lipid Sink in Verapamil Poisoning.

Kryshtal DO, Dawling S, Seger D, Knollmann BC.

J Med Toxicol. 2016 Jun;12(2):165-71. doi: 10.1007/s13181-015-0511-y.

3.

Resolution of an apparent hook effect in Roche partner DRI oxycodone immunoassay.

Colón-Franco JM, Cox ET, Crosby DB, Dawling S.

J Anal Toxicol. 2013 Jul-Aug;37(6):376-81. doi: 10.1093/jat/bkt044. Epub 2013 May 27.

PMID:
23711948
4.

Primary prevention of pediatric lead exposure requires new approaches to transfusion screening.

Gehrie E, Keiser A, Dawling S, Travis J, Strathmann FG, Booth GS.

J Pediatr. 2013 Sep;163(3):855-9. doi: 10.1016/j.jpeds.2013.03.003. Epub 2013 Apr 10.

5.

Estrogen metabolism and exposure in a genotypic-phenotypic model for breast cancer risk prediction.

Crooke PS, Justenhoven C, Brauch H; GENICA Consortium, Dawling S, Roodi N, Higginbotham KS, Plummer WD, Schuyler PA, Sanders ME, Page DL, Smith JR, Dupont WD, Parl FF.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1502-15. doi: 10.1158/1055-9965.EPI-11-0060. Epub 2011 May 24.

6.

Estrogen metabolism and breast cancer: a risk model.

Parl FF, Dawling S, Roodi N, Crooke PS.

Ann N Y Acad Sci. 2009 Feb;1155:68-75. doi: 10.1111/j.1749-6632.2008.03676.x. Review.

7.

Effects of a selective serotonin reuptake inhibitor, fluoxetine, on counterregulatory responses to hypoglycemia in healthy individuals.

Briscoe VJ, Ertl AC, Tate DB, Dawling S, Davis SN.

Diabetes. 2008 Sep;57(9):2453-60. doi: 10.2337/db08-0236. Epub 2008 Jun 20.

8.

Cytochrome P450 1B1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation.

Belous AR, Hachey DL, Dawling S, Roodi N, Parl FF.

Cancer Res. 2007 Jan 15;67(2):812-7.

9.

Estrogens, enzyme variants, and breast cancer: a risk model.

Crooke PS, Ritchie MD, Hachey DL, Dawling S, Roodi N, Parl FF.

Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1620-9.

10.

Unmasked adult-onset urea cycle disorders in the critical care setting.

Summar ML, Barr F, Dawling S, Smith W, Lee B, Singh RH, Rhead WJ, Sniderman King L, Christman BW.

Crit Care Clin. 2005 Oct;21(4 Suppl):S1-8. Review.

PMID:
16227111
11.
12.
13.

Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1.

Dawling S, Roodi N, Parl FF.

Cancer Res. 2003 Jun 15;63(12):3127-32.

14.

Sudden, unexpected cardiac or unexplained death in England: a national survey.

Bowker TJ, Wood DA, Davies MJ, Sheppard MN, Cary NR, Burton JD, Chambers DR, Dawling S, Hobson HL, Pyke SD, Riemersma RA, Thompson SG.

QJM. 2003 Apr;96(4):269-79.

PMID:
12651971
15.
16.

Neonatal pulmonary hypertension--urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function.

Pearson DL, Dawling S, Walsh WF, Haines JL, Christman BW, Bazyk A, Scott N, Summar ML.

N Engl J Med. 2001 Jun 14;344(24):1832-8.

17.
18.

Stabilizing blood with 3-deazaadenosine interferes in the Abbott FPIA assay for plasma homocyst(e)ine.

Dawling S.

Ann Clin Biochem. 1999 Sep;36 ( Pt 5):669-70. No abstract available.

PMID:
10505221
19.

Physiologic effects of anesthesia induced and maintained by intravenous administration of a climazolam-ketamine combination in ponies premedicated with acepromazine and xylazine.

Bettschart-Wolfensberger R, Taylor PM, Sear JW, Bloomfield MR, Rentsch K, Dawling S.

Am J Vet Res. 1996 Oct;57(10):1472-7.

PMID:
8896687
20.

Thyroxine replacement increases central 5-hydroxytryptamine activity and reduces depressive symptoms in hypothyroidism.

Cleare AJ, McGregor A, Chambers SM, Dawling S, O'Keane V.

Neuroendocrinology. 1996 Jul;64(1):65-9.

PMID:
8811668
21.

Systemic absorption and abuse liability of snorted flunitrazepam.

Bond A, Seijas D, Dawling S, Lader M.

Addiction. 1994 Jul;89(7):821-30.

PMID:
8081180
22.

Systemic paraphenylenediamine (PPD) poisoning: a case report and review.

Ashraf W, Dawling S, Farrow LJ.

Hum Exp Toxicol. 1994 Mar;13(3):167-70. Review.

PMID:
7909678
23.

Folinic acid and enhanced renal elimination in formic acid intoxication.

Moore DF, Bentley AM, Dawling S, Hoare AM, Henry JA.

J Toxicol Clin Toxicol. 1994;32(2):199-204.

PMID:
8145360
24.

Health effects of organophosphate sheep dips.

Murray VS, Wiseman HM, Dawling S, Morgan I, House IM.

BMJ. 1992 Oct 31;305(6861):1090. No abstract available.

25.

Accidental ingestion of 'Ecstasy' (3,4-methylenedioxymethylamphetamine).

Bedford Russell AR, Schwartz RH, Dawling S.

Arch Dis Child. 1992 Sep;67(9):1114-5.

26.

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

Henry JA, Jeffreys KJ, Dawling S.

Lancet. 1992 Aug 15;340(8816):384-7.

PMID:
1353554
27.

Noradrenaline uptake inhibition increases melatonin secretion, a measure of noradrenergic neurotransmission, in depressed patients.

Palazidou E, Papadopoulos A, Ratcliff H, Dawling S, Checkley SA.

Psychol Med. 1992 May;22(2):309-15.

PMID:
1319597
28.

Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man.

Gray NS, Pickering AD, Hemsley DR, Dawling S, Gray JA.

Psychopharmacology (Berl). 1992;107(2-3):425-30.

PMID:
1615140
29.

Predicting severity of tricyclic antidepressant overdose.

Hultén BA, Adams R, Askenasi R, Dallos V, Dawling S, Volans G, Heath A.

J Toxicol Clin Toxicol. 1992;30(2):161-70.

PMID:
1588666
30.

Excretion of fluvoxamine in breast milk.

Wright S, Dawling S, Ashford JJ.

Br J Clin Pharmacol. 1991 Feb;31(2):209. No abstract available.

31.

Comparative effects of the diastereoisomers, quinine and quinidine in producing phenocopy debrisoquine poor metabolisers (PMs) in healthy volunteers.

Ayesh R, Dawling S, Hayler A, Oates NS, Cholerton S, Widdop B, Idle JR, Smith RL.

Chirality. 1991;3(1):14-8.

PMID:
2039678
32.

Gas chromatographic measurement of cocaine in serum, plasma and whole blood.

Dawling S, Essex EG, Ward N, Widdop B.

Ann Clin Biochem. 1990 Sep;27 ( Pt 5):478-81.

PMID:
2281928
33.

Rapid measurement of basic drugs in blood applied to clinical and forensic toxicology.

Dawling S, Ward N, Essex EG, Widdop B.

Ann Clin Biochem. 1990 Sep;27 ( Pt 5):473-7.

PMID:
2281927
34.

The in-vitro and ex-vivo effects of chloroquine sulphate on platelet function: implications for malaria prophylaxis in patients with impaired haemostasis.

Cummins D, Faint R, Yardumian DA, Dawling S, Mackie I, Machin SJ.

J Trop Med Hyg. 1990 Apr;93(2):112-5.

PMID:
2325191
35.

Crotamiton overdose.

Meredith TJ, Dawling S, McNicol MW.

Hum Exp Toxicol. 1990 Jan;9(1):57. No abstract available.

PMID:
2328154
36.

Positive diagnosis of self-medication with homatropine eye drops.

Warrens AN, Ron MA, Dawling S.

Br J Psychiatry. 1990 Jan;156:124-5.

PMID:
2297609
37.

Clinical pharmacokinetic considerations in the elderly. An update.

Dawling S, Crome P.

Clin Pharmacokinet. 1989 Oct;17(4):236-63. Review.

PMID:
2686883
38.

Thiopental infusion in the treatment of intracranial hypertension complicating fulminant hepatic failure.

Forbes A, Alexander GJ, O'Grady JG, Keays R, Gullan R, Dawling S, Williams R.

Hepatology. 1989 Sep;10(3):306-10.

PMID:
2759548
39.

Fatal lignocaine poisoning: report of two cases and review of the literature.

Dawling S, Flanagan RJ, Widdop B.

Hum Toxicol. 1989 Sep;8(5):389-92. Review.

PMID:
2680899
40.

Extra-hepatic metabolism of midazolam.

Park GR, Manara AR, Dawling S.

Br J Clin Pharmacol. 1989 May;27(5):634-7.

41.

Use and abuse of the Toxi-Lab TLC system.

Dawling S, Widdop B.

Ann Clin Biochem. 1988 Nov;25 ( Pt 6):708-9. No abstract available.

PMID:
3254114
42.

Activated charcoal in tricyclic antidepressant poisoning.

Hultén BA, Adams R, Askenasi R, Dallos V, Dawling S, Heath A, Volans G.

Hum Toxicol. 1988 Jul;7(4):307-10.

PMID:
3410479
44.

Application of an individually predicted dosage of amitriptyline to the treatment of depression.

Roy D, Dawling S.

Int Clin Psychopharmacol. 1987 Oct;2(4):307-15.

PMID:
3693870
45.
46.

Plasma concentrations of mianserin after single dose and at steady-state in depressed elderly patients.

Dawling S, Ford S, Ariyanayagam P, O'Neal H, Lewis RR.

Clin Pharmacokinet. 1987 Jan;12(1):73-8.

PMID:
3816006
47.

Accumulation of midazolam after repeated dosage in patients receiving mechanical ventilation in an intensive care unit.

Byatt CM, Lewis LD, Dawling S, Cochrane GM.

Br Med J (Clin Res Ed). 1984 Sep 29;289(6448):799-800. No abstract available.

48.

A comparison of diazepam and midazolam as sedatives for minor oral surgery.

Skelly AM, Boscoe MJ, Dawling S, Adams AP.

Eur J Anaesthesiol. 1984 Sep;1(3):253-67.

PMID:
6536515
49.

Value of serum diazepam and nordiazepam measurements in anxious patients.

Tyrer P, Treasaden I, Moreton K, Riley P, Flanagan RJ, Dawling S.

J Affect Disord. 1984 Aug;7(1):1-10.

PMID:
6236239
50.

Amitriptyline dosage prediction in elderly patients from plasma concentration at 24 hours after a single 100mg dose.

Dawling S, Ford S, Rangedara DC, Lewis RR.

Clin Pharmacokinet. 1984 May-Jun;9(3):261-6.

PMID:
6734015

Supplemental Content

Loading ...
Support Center